Banka Bioloo (BANKA) | Financial Analysis & Statements
Banka Bioloo Ltd. Small-cap Industrials
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
111.4M
Gross Profit
99.8M
89.59%
Operating Income
-3.0M
-2.66%
Net Income
21.0K
0.02%
EPS (Diluted)
₹0.00
Balance Sheet Metrics
Total Assets
821.6M
Total Liabilities
505.7M
Shareholders Equity
315.9M
Debt to Equity
1.60
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Banka Bioloo Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 541.7M | 500.0M | 423.5M | 387.5M | 304.6M |
| Cost of Goods Sold | 159.6M | 162.4M | 55.4M | 67.2M | 38.1M |
| Gross Profit | 382.2M | 337.6M | 368.1M | 320.3M | 266.5M |
| Gross Margin % | 70.5% | 67.5% | 86.9% | 82.7% | 87.5% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 25.0M | 22.5M | 19.5M | 17.5M | 17.0M |
| Other Operating Expenses | 59.3M | 34.6M | 47.5M | 65.7M | 76.6M |
| Total Operating Expenses | 84.3M | 57.1M | 67.0M | 83.3M | 93.6M |
| Operating Income | -20.8M | 17.4M | 47.1M | 46.2M | 28.5M |
| Operating Margin % | -3.8% | 3.5% | 11.1% | 11.9% | 9.4% |
| Non-Operating Items | |||||
| Interest Income | 2.5M | 3.8M | 5.6M | 3.9M | 4.8M |
| Interest Expense | 33.9M | 23.9M | 15.0M | 16.4M | 14.7M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | -91.2M | -5.6M | 36.2M | 33.1M | 18.7M |
| Income Tax | -2.2M | 1.1M | 10.9M | 2.0M | -3.4M |
| Effective Tax Rate % | 0.0% | 0.0% | 29.9% | 6.1% | -18.0% |
| Net Income | -89.1M | -6.7M | 25.4M | 31.1M | 22.0M |
| Net Margin % | -16.4% | -1.3% | 6.0% | 8.0% | 7.2% |
| Key Metrics | |||||
| EBITDA | 4.0M | 40.2M | 66.1M | 58.9M | 39.2M |
| EPS (Basic) | ₹-8.21 | ₹-0.60 | ₹2.34 | ₹3.02 | ₹2.14 |
| EPS (Diluted) | ₹-8.21 | ₹-0.60 | ₹2.34 | ₹3.02 | ₹2.14 |
| Basic Shares Outstanding | 10850000 | 10800000 | 10800000 | 10300000 | 10281120 |
| Diluted Shares Outstanding | 10850000 | 10800000 | 10800000 | 10300000 | 10281120 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Banka Bioloo Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 2.5M | 3.1M | 8.4M | 3.2M | 18.1M |
| Short-term Investments | 64.4M | 40.7M | 5.0M | 5.1M | 25.2M |
| Accounts Receivable | 143.7M | 229.6M | 229.3M | 203.6M | 116.8M |
| Inventory | 58.2M | 82.6M | 87.2M | 83.9M | 80.3M |
| Other Current Assets | 32.7M | 1.0K | -1.0K | 3.0M | 2.5M |
| Total Current Assets | 532.4M | 493.4M | 414.8M | 475.6M | 360.1M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 11.2M | 140.5M | 88.0M | 31.0M | 22.1M |
| Goodwill | 905.0K | 7.4M | 7.3M | 7.3M | 1.2M |
| Intangible Assets | 905.0K | 1.1M | 982.0K | 1.0M | 1.2M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 3.0K | 1.0K | 55.6M | 50.2M | 1.4M |
| Total Non-Current Assets | 289.1M | 280.8M | 237.2M | 165.0M | 103.6M |
| Total Assets | 821.6M | 774.2M | 652.1M | 640.5M | 463.7M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 54.5M | 39.3M | 31.5M | 36.6M | 24.9M |
| Short-term Debt | 230.6M | 145.3M | 106.5M | 93.9M | 48.8M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 18.7M | 9.6M | 29.3M | 11.8M | 3.4M |
| Total Current Liabilities | 378.9M | 253.5M | 184.0M | 171.5M | 91.9M |
| Non-Current Liabilities | |||||
| Long-term Debt | 116.7M | 113.9M | 60.7M | 91.1M | 68.2M |
| Deferred Tax Liabilities | 2.1M | 3.6M | 2.2M | 0 | 0 |
| Other Non-Current Liabilities | - | 15.0K | -36.0K | -2.0K | 98 |
| Total Non-Current Liabilities | 126.8M | 123.1M | 67.1M | 94.0M | 71.5M |
| Total Liabilities | 505.7M | 376.6M | 251.1M | 265.5M | 163.4M |
| Equity | |||||
| Common Stock | 108.7M | 108.5M | 108.5M | 108.5M | 102.8M |
| Retained Earnings | 109.3M | 203.6M | 207.4M | 179.6M | 148.6M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 315.9M | 397.6M | 401.0M | 375.0M | 300.3M |
| Key Metrics | |||||
| Total Debt | 347.3M | 259.1M | 167.2M | 185.0M | 117.0M |
| Working Capital | 153.5M | 239.9M | 230.8M | 304.1M | 268.1M |
Balance Sheet Composition
Banka Bioloo Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -91.2M | -5.6M | 36.2M | 33.1M | 18.7M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | 22.0M | -13.6M | 26.8M | -53.9M | 44.4M |
| Operating Cash Flow | -34.9M | 617.0K | 71.6M | -7.9M | 73.5M |
| Investing Activities | |||||
| Capital Expenditures | -44.4M | -99.7M | -64.1M | -31.6M | -5.1M |
| Acquisitions | -20.0K | - | - | - | - |
| Investment Purchases | - | - | - | -168.2K | -232.7K |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -44.5M | -99.7M | -64.1M | -31.7M | -5.3M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | - | -4.1M |
| Debt Issuance | - | - | - | - | - |
| Debt Repayment | - | - | - | - | - |
| Financing Cash Flow | 276.0K | 38.3M | 11.7M | 26.7M | -5.2M |
| Free Cash Flow | -36.1M | -72.1M | 9.4M | -36.0M | 53.5M |
| Net Change in Cash | -79.1M | -60.8M | 19.2M | -12.9M | 63.0M |
Cash Flow Trend
Banka Bioloo Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
57.14
Price to Book
2.53
Price to Sales
1.43
PEG Ratio
-0.64
Profitability Ratios
Profit Margin
-5.26%
Operating Margin
4.49%
Return on Equity
-28.23%
Return on Assets
-10.85%
Financial Health
Current Ratio
1.21
Debt to Equity
105.55
Beta
0.35
Per Share Data
EPS (TTM)
₹-2.62
Book Value per Share
₹28.23
Revenue per Share
₹49.93
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| BANKA | 782.9M | 57.14 | 2.53 | -28.23% | -5.26% | 105.55 |
| Ion Exchange (India | 49.7B | 26.60 | 3.74 | 17.18% | 6.30% | 32.49 |
| Filtra Consultants | 646.9M | 22.78 | 2.68 | 11.66% | 3.05% | 7.79 |
| Quality RO | 150.1M | 7.77 | 1.27 | 17.84% | 11.51% | 61.45 |
| Rudrabhishek | 101.1B | 26.50 | 6.19 | 0.00% | 15.76% | - |
Financial data is updated regularly. All figures are in the company's reporting currency.



